Evaluation of Cerebellar Ataxic Patients

Koziol L.F. Budding D. Andreasen N. et al.

Consensus paper: the cerebellum's role in movement and cognition.

Cerebellum. 13: 151-177Guell X. Gabrieli J.D.E. Schmahmann J.D.

Embodied cognition and the cerebellum: Perspectives from the Dysmetria of Thought and the Universal Cerebellar Transform theories.

Cortex. 100: 140-148

The cerebellum and cognition.

Neurosci Lett. 688: 62-75Roostaei T. Nazeri A. Sahraian M.A. et al.

The human cerebellum: a review of physiologic neuroanatomy.

Neurol Clin. 32: 859-869Manto M. Bower J.M. Conforto A.B. et al.

Consensus paper: roles of the cerebellum in motor control--the diversity of ideas on cerebellar involvement in movement.

Cerebellum. 11: 457-487Schmahmann J.D. Pandya D.N.

The cerebrocerebellar system.

Int Rev Neurobiol. 41: 31-60Schmahmann J.D. Pandya D.N.

Projections to the basis pontis from the superior temporal sulcus and superior temporal region in the rhesus monkey.

J Comp Neurol. 308: 224-248Schmahmann J.D. Pandya D.N.

Anatomic organization of the basilar pontine projections from prefrontal cortices in rhesus monkey.

J Neurosci. 17: 438-458

An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex.

J Neurophysiol. 89: 634-639Schmahmann J.D. Sherman J.C.

The cerebellar cognitive affective syndrome.

Brain. 121: 561-579Amokrane N. Viswanathan A. Freedman S. et al.

Impulsivity in Cerebellar Ataxias: Testing the Cerebellar Reward Hypothesis in Humans.

Mov Disord. 35: 1491-1493Amokrane N. Lin C.R. Desai N.A. et al.

The Impact of Compulsivity and Impulsivity in Cerebellar Ataxia: A Case Series.

Tremor Other Hyperkinet Mov (N Y). 10: 43Lo R.Y. Figueroa K.P. Pulst S.M. et al.

Depression and clinical progression in spinocerebellar ataxias.

Parkinsonism Relat Disord. 22: 87-92Benrud-Larson L.M. Sandroni P. Schrag A. et al.

Depressive symptoms and life satisfaction in patients with multiple system atrophy.

Mov Disord. 20: 951-957Luo L. Wang J. Lo R.Y. et al.

The Initial Symptom and Motor Progression in Spinocerebellar Ataxias.

Cerebellum. 16: 615-622Termsarasab P. Thammongkolchai T. Rucker J.C. et al.

The diagnostic value of saccades in movement disorder patients: a practical guide and review.

J Clin Mov Disord. 2: 14Rascol O. Sabatini U. Simonetta-Moreau M. et al.

Square wave jerks in parkinsonian syndromes.

J Neurol Neurosurg Psychiatry. 54: 599-602

The neurology of eye movements.

Oxford University Press, Shaikh A.G. Ramat S. Optican L.M. et al.

Saccadic burst cell membrane dysfunction is responsible for saccadic oscillations.

J Neuroophthalmol. 28: 329-336Kim M. Ahn J.H. Mun J.K. et al.

Extracerebellar Signs and Symptoms in 117 Korean Patients with Early-Stage Spinocerebellar Ataxia.

J Clin Neurol. 17: 242-248Stephen C.D. Schmahmann J.D.

Eye Movement Abnormalities Are Ubiquitous in the Spinocerebellar Ataxias.

Cerebellum. 18: 1130-1136

Love RJ, Webb WG. The Neuromotor Control of Speech. Neurology for the Speech-Language Pathologist. 2nd edition. Butterworth-Heinemann; 1992:81-111: Chapter 6.

Gan S.R. Wang J. Figueroa K.P. et al.

Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.

Tremor Other Hyperkinet Mov (N Y). 7: 492Lai R.Y. Tomishon D. Figueroa K.P. et al.

Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor.

Cerebellum. 18: 519-526Hoche F. Guell X. Vangel M.G. et al.

The cerebellar cognitive affective/Schmahmann syndrome scale.

Brain. 141: 248-270Nie S. Chen G. Cao X. et al.

Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.

Orphanet J Rare Dis. 9: 179Schmitz-Hübsch T. du Montcel S.T. Baliko L. et al.

Scale for the assessment and rating of ataxia: development of a new clinical scale.

Neurology. 66: 1717-1720Ashizawa T. Figueroa K.P. Perlman S.L. et al.

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.

Orphanet J Rare Dis. 8: 177Jacobi H. Bauer P. Giunti P. et al.

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.

Neurology. 77: 1035-1041Chen M.L. Lin C.C. Rosenthal L.S. et al.

Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.

J Neurol Sci. 424: 117417Schmahmann J.D. Gardner R. MacMore J. et al.

Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS.

Mov Disord. 24: 1820-1828

Acute cerebellitis.

Cerebellum. 1: 223-228Lancella L. Esposito S. Galli M.L. et al.

Acute cerebellitis in children: an eleven year retrospective multicentric study in Italy.

Ital J Pediatr. 43: 54Nussinovitch M. Prais D. Volovitz B. et al.

Post-infectious acute cerebellar ataxia in children.

Clin Pediatr (Phila). 42: 581-584Bozzola E. Bozzola M. Tozzi A.E. et al.

Acute cerebellitis in varicella: a ten year case series and systematic review of the literature.

Ital J Pediatr. 40: 57

The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Mov Disord Clin Pract. 1: 285-290Pavone P. Praticò A.D. Pavone V. et al.

Ataxia in children: early recognition and clinical evaluation.

Ital J Pediatr. 43: 6Moseley M.L. Benzow K.A. Schut L.J. et al.

Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families.

Neurology. 51: 1666-1671Ruano L. Melo C. Silva M.C. et al.

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.

Neuroepidemiology. 42: 174-183Schöls L. Bauer P. Schmidt T. et al.

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

Lancet Neurol. 3: 291-304Jacobi H. du Montcel S.T. Bauer P. et al.

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.

Lancet Neurol. 14: 1101-1108Park H. Kim H.J. Jeon B.S.

Parkinsonism in spinocerebellar ataxia.

Biomed Res Int. 2015: 125273Yabe I. Sasaki H. Takeichi N. et al.

Positional vertigo and macroscopic downbeat positioning nystagmus in spinocerebellar ataxia type 6 (SCA6).

J Neurol. 250: 440-443Michalik A. Martin J.J. Van Broeckhoven C.

Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.

Eur J Hum Genet. 12: 2-15Ashizawa T. Öz G. Paulson H.L.

Spinocerebellar ataxias: prospects and challenges for therapy development.

Nat Rev Neurol. 14: 590-605Gupta D.K. Blanco-Palmero V.A. Chung W.K. et al.

Abnormal Vertical Eye Movements as a Clue for Diagnosis of Niemann-Pick Type C.

Tremor Other Hyperkinet Mov (N Y). 8: 560Szmulewicz D.J. Roberts L. McLean C.A. et al.

Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS).

Neurol Clin Pract. 6: 61-68

Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment.

J Investig Med. 57: 830-836Ilg W. Synofzik M. Brötz D. et al.

Intensive coordinative training improves motor performance in degenerative cerebellar disease.

Neurology. 73: 1823-1830Miyai I. Ito M. Hattori N. et al.

Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.

Neurorehabil Neural Repair. 26: 515-522

A home balance exercise program improves walking in people with cerebellar ataxia.

Neurorehabil Neural Repair. 28: 770-778

Motor training in degenerative spinocerebellar disease: ataxia-specific improvements by intensive physiotherapy and exergames.

Biomed Res Int. 2014: 583507Ristori G. Romano S. Visconti A. et al.

Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.

Neurology. 74: 839-845Romano S. Coarelli G. Marcotulli C. et al.

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.

Lancet Neurol. 14: 985-991Lei L.F. Yang G.P. Wang J.L. et al.

Safety and efficacy of valproic acid treatment in SCA3/MJD patients.

Parkinsonism Relat Disord. 26: 55-61Zesiewicz T.A. Greenstein P.E. Sullivan K.L. et al.

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.

Neurology. 78: 545-550Lo R.Y. Figueroa K.P. Pulst S.M. et al.

Coenzyme Q10 and spinocerebellar ataxias.

Mov Disord. 30: 214-220

Coenzyme Q10 as a Peripheral Biomarker for Multiple System Atrophy.

JAMA Neurol. 73: 917-919Nakamoto F.K. Okamoto S. Mitsui J. et al.

The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy.

Sci Rep. 8: 14215Jen J.C. Graves T.D. Hess E.J. et al.

Primary episodic ataxias: diagnosis, pathogenesis and treatment.

Brain. 130: 2484-2493Yabe I. Sasaki H. Yamashita I. et al.

Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry.

Acta Neurol Scand. 104: 44-47Jen J.C. Yue Q. Karrim J. et al.

Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia.

J Neurol Neurosurg Psychiatry. 65: 565-568Zesiewicz T.A. Wilmot G. Kuo S.H. et al.

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Neurology. 90: 464-471Thurtell M.J. Joshi A.C. Leone A.C. et al.

Crossover trial of gabapentin and memantine as treatment for acquired nystagmus.

Ann Neurol. 67: 676-680Tsunemi T. Ishikawa K. Tsukui K. et al.

The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.

J Neurol Sci. 292: 81-84Toonen L.J. Schmidt I. Luijsterburg M.S. et al.

Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.

Sci Rep. 6: 35200Cury R.G. França C. Duarte K.P. et al.

Safety and Outcomes of Dentate Nucleus Deep Brain Stimulation for Cerebellar Ataxia.

Cerebellum. https://doi.org/10.1007/s12311-021-01326-8Teixeira M.J. Cury R.G. Galhardoni R. et al.

Deep brain stimulation of the dentate nucleus improves cerebellar ataxia after cerebellar stroke.

Neurology. 85: 2075-2076Chen T.X. Yang C.Y. Willson G. et al.

The Efficacy and Safety of Transcranial Direct Current Stimulation for Cerebellar Ataxia: a Systematic Review and Meta-Analysis.

Cerebellum. 20: 124-133Maas R.P.P.W. Toni I. Doorduin J. et al.

Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3 (SCA3-tDCS): rationale and protocol of a randomized, double-blind, sham-controlled study.

BMC Neurol. 19: 149Manor B. Greenstein P.E. Davila-Perez P. et al.

Repetitive Transcranial Magnetic Stimulation in Spinocerebellar Ataxia: A Pilot Randomized Controlled Trial.

Front Neurol. 10: 73

留言 (0)

沒有登入
gif